1255099-41-2 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Aminospiro[3.3]heptane is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with novel mechanisms of action and improved therapeutic properties.
Used in Agrochemical Synthesis:
In the agrochemical industry, 2-Aminospiro[3.3]heptane is utilized as a building block for the creation of new agrochemicals. Its incorporation into these compounds can lead to enhanced pest control and crop protection.
Used in Organic Compound Synthesis:
2-Aminospiro[3.3]heptane serves as a versatile starting material for the synthesis of a wide range of organic compounds. Its unique spirocyclic structure and amino group provide opportunities for the development of new chemical entities with diverse applications.
Used in Biological and Pharmacological Research:
Due to its potential biological and pharmacological activities, 2-Aminospiro[3.3]heptane is used in research to explore its effects on various biological systems. This can lead to a better understanding of its properties and the discovery of new therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1255099-41-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,5,0,9 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1255099-41:
(9*1)+(8*2)+(7*5)+(6*5)+(5*0)+(4*9)+(3*9)+(2*4)+(1*1)=162
162 % 10 = 2
So 1255099-41-2 is a valid CAS Registry Number.
1255099-41-2Relevant academic research and scientific papers
B-LACTAMASE INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0257; 0258, (2018/03/07)
The present invention relates to a compound of Formula (I)-(IV) useful as β-lactamase inhibitor, a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, wherein R1, R2, M and ring A have definitions as those in the specification. The present invention further relates to methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and uses of these compounds. For example, the compounds of the present invention can be used as β-lactamase inhibitors, for treatment and/or prophylaxis of diseases caused by bacterial infections, solving drug-resistance problems caused by β-lactamases, especially bacterial drug-resistant diseases caused by type B metallo-β-lactamases.
